Skip to main content
Premium Trial:

Request an Annual Quote

That's Entertainment!

If you're going to dance the proteome, make sure you've got plenty of friends.

That's the advice of Anna-Maria Lahesmaa-Korpinen, a researcher at the Finnish Institute of National Health and Welfare and creator of the below video —a depiction in dance of the cancer proteome.

Lahesmaa-Korpinen came up with the dance as an entry in Finland's ScienceSLAM competition — an event run by a group of Helsinki-based researchers in which scientists take the stage to present their research via performance pieces.

With a group of friends and colleagues — including a few currently studying directing and cinematography — Lahesmaa-Korpinen choreographed a take on her recently completed PhD thesis — an investigation into computational approaches in high-throughput proteomics data analysis.

A life-long dancer, "it was sort of a natural thing to use dance for communicating what I've been doing for my PhD research," Lahesmaa-Korpinen tells the Daily Scan.

As for actually putting the piece together, rounding up a large enough cast was key. "Having a dance about proteomics with only two or three dancers would have been kind of incomplete," she says.

"I also think proteomics-related studies are optimal for visualization with dance, since things like interactions, signals and structures can be quite naturally depicted using dancers," Lahesmaa-Korpinen adds.

The proteomics world may have to wait a while before it's again immortalized in dance, though. Since defending her thesis this summer Lahesmaa-Korpinen has shifted her research focus towards public health.

"I've moved away from proteomics," she says. "But, of course, I will continue following the field because it's always been inspirational and there are a lot of exciting things happening."

The choreography of the cancer proteome from Anna-Maria Lahesmaa-Korpinen on Vimeo.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.